Publications by authors named "Katherine Winfree"

Claim this Profile
C
Clinical trial participation, clinical care, and patient outcomes by practice setting: a real-world database analysis of patients with Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma.
Debora S Bruno, Manoj Khanal, Xiaohong Li, Maricer P Escalon, Katherine Winfree

Hematology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuity of care for patients with chronic lymphocytic leukemia: an analysis of real-world data.
Sameh Gaballa, Manoj Khanal, Yongmei Chen, Naleen Raj Bhandari, Katherine B Winfree

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes after discontinuation of covalent BTK inhibitor-based therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Nitin Jain, Toby A Eyre, Katherine B Winfree, Naleen Raj Bhandari, Manoj Khanal

Leuk Lymphoma· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Ethnic Characteristics and Outcomes of Patients Diagnosed with CLL/SLL in the USA.
Debora S Bruno, Manoj Khanal, Xiaohong I Li, Maricer P Escalon, Katherine B Winfree

Acta Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian survival extrapolation for cost-effectiveness analysis: a case study of RELAY for ramucirumab in combination with erlotinib in the treatment of non-small-cell lung cancer.
Sory Traore, Andreas Sashegyi, Katherine B Winfree, Kaisa-Leena Taipale, Min-Hua Jen

J Med Econ· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study.
Cliff Molife, Katherine B Winfree, Hollie Bailey, Yulia D'yachkova, Cameron Forshaw

Adv Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancer.
Himani Aggarwal, Kerigo Ndirangu, Katherine B Winfree, Catherine Elizabeth Muehlenbein, Emily Zhu

J Comp Eff Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of first-line therapies in -mutated advanced non-small-cell lung cancer: a network meta-analysis.
Katrin Haeussler, Xuan Wang, Katherine B Winfree, Yulia D'yachkova, Sory Traore

Future Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of patient characteristics, treatment patterns, testing patterns and outcomes in real-world patients with m non-small cell lung cancer.
Katherine B Winfree, Kristin M Sheffield, Zhanglin Lin Cui, Tomoko Sugihara, Josephine Feliciano

Curr Med Res Opin· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with exon 19 deletions or exon 21 mutations.
Katherine B Winfree, Cliff Molife, Patrick M Peterson, Yongmei Chen, Carla M Visseren-Grul

Future Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data Integration to Improve Real-world Health Outcomes Research for Non-Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration.
Michael Grabner, Cliff Molife, Liya Wang, Katherine B Winfree, Zhanglin Lin Cui

JMIR Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study.
Edward B Garon, Katherine B Winfree, Cliff Molife, Zhanglin Lin Cui, Edurne Arriola

Support Care Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reweighting Randomized Controlled Trial Evidence to Better Reflect Real Life - A Case Study of the Innovative Medicines Initiative.
Michael Happich, Alan Brnabic, Douglas Faries, Keith Abrams, Katherine B Winfree

Clin Pharmacol Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated -mutated metastatic non-small-cell lung cancer.
Kiyotaka Yoh, Shinji Atagi, Martin Reck, Edward B Garon, Santiago Ponce Aix, Katherine B Winfree

Curr Med Res Opin· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Debunking Myths While Understanding Limitations.
Lisa M Hess, Katherine B Winfree, Catherine E Muehlenbein, Yajun E Zhu, Ana B Oton

Am J Public Health· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer.
Ramaswamy Govindan, Suresh Senan, Nicolas Dickgreber, Mariano Provencio, Yi-Long Wu, Katherine Winfree

Curr Med Res Opin· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns, duration and outcomes of pemetrexed maintenance therapy in patients with advanced NSCLC in a real-world setting.
Katherine B Winfree, Aracelis Z Torres, Yajun Emily Zhu, Catherine Muehlenbein, Himani Aggarwal

Curr Med Res Opin· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer.
Maurice Pérol, Katherine B Winfree, Gebra Cuyun Carter, Zhanglin Lin Cui, Lee Bowman

Lung Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy.
Suzanne McMullen, Lisa M Hess, Edward S Kim, Benjamin Levy, Mohamed Mohamed, Katherine B Winfree

Patient· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis.
Adrian D Vickers, Katherine B Winfree, Gebra Cuyun Carter, Urpo Kiiskinen, Min-Hua Jen

BMC Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns by EGFR Mutation Status in Non-Small Cell Lung Cancer Patients in the USA: A Retrospective Database Analysis.
Kathleen M Aguilar, Katherine B Winfree, Catherine E Muehlenbein, Yajun Emily Zhu, Thomas Wilson

Adv Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting.
Martin Reck, Marina Chiara Garassino, Martina Imbimbo, Frances A Shepherd, Mark A Socinski, Katherine B Winfree

Lung Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.
Suresh S Ramalingam, Maurice Pérol, Martin Reck, Ruben Dario Kowalyszyn, Oliver Gautschi, Katherine B Winfree

Clin Lung Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol.
Lisa M Hess, David M Kern, Gebra Cuyun Carter, Katherine Winfree, Liya Wang

JMIR Res Protoc· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France.
Kaisa Taipale, Katherine B Winfree, Mark Boye, Mickael Basson, Ghassan Sleilaty

Clinicoecon Outcomes Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis